Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Hypotension	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
year-old	O
woman	O
with	O
a	O
history	O
of	O
sCHF	O
(EF	O
25%	O
in	O
___	O
s/p	O
ICD	O
placement,	O
CAD	O
with	O
twin	O
LAD	O
system	O
on	O
___	O
cath,	O
and	O
AFib	O
on	O
coumadin	O
who	O
presented	O
for	O
abnormal	O
EKG	O
findings	O
found	O
to	O
be	O
hypotensive.	O
Today	O
___,	O
the	O
patient	O
went	O
to	O
outpatient	O
pre-op	O
appointment	O
for	O
planned	O
LLE	O
cyst	O
removal	O
on	O
___.	O
During	O
triage,	O
patient	O
was	O
found	O
to	O
have	O
concerning	O
EKG	O
changes	O
(unavailable	O
for	O
viewing),	O
and	O
subsequently	O
sent	O
into	O
___	O
ED	O
for	O
further	O
evaluation.	O
In	O
ED,	O
In	O
the	O
ED,	O
initial	O
VS	O
were	O
96.7	O
66	O
113/58	O
18	O
96%.	O
Labs	O
were	O
notable	O
for	O
unremarkable	O
CBC,	O
unremarkable	O
LFTs,	O
Chem-7	O
with	O
K	O
5.6	O
and	O
BUN/Cr	O
98/3.9,	O
Coags	O
with	O
INR	O
3.0,	O
proBNP	O
3050,	O
lactate	O
0.9,	O
and	O
ABG	O
7.___.	O
CXR	O
showed	O
cardiomegaly,	O
AICD	O
leads	O
in	O
RA	O
and	O
RV,	O
no	O
acute	O
intrathoracic	O
process,	O
calcified	O
left	O
ventricular	O
aneurysm.	O
Bedside	O
ECHO	O
notable	O
for	O
minimal	O
pericardial	O
effusion	O
without	O
tamponade	O
physiology,	O
normal	O
RV	O
function,	O
poor	O
LV	O
function.	O
While	O
in	O
the	O
ED,	O
the	O
patient	O
was	O
found	O
to	O
be	O
hypotensive	O
to	O
sBP	O
70-80s,	O
for	O
which	O
RIJ	O
line	O
was	O
placed,	O
patient	O
was	O
started	O
on	O
norepinephrine	O
and	O
administered	O
fluid	O
boluses	O
(2x	O
250cc	O
NS)	O
with	O
improvement	O
in	O
SBP	O
to	O
120s.	O
She	O
was	O
also	O
administered	O
Vancomycin/Cefepime	O
x	O
1	O
for	O
a	O
concern	O
for	O
sepsis.	O
CVP	O
was	O
measured	O
___	O
VS	O
prior	O
to	O
transfer	O
were	O
59	O
114/72	O
19	O
99%RA.	O
Upon	O
arrival	O
to	O
the	O
floor,	O
VS	O
were	O
on	O
0.12	O
Levophed.	O
Patient	O
was	O
otherwise	O
well-appearing	O
without	O
complaint.	O
EKG	O
upon	O
arrival	O
notable	O
for	O
ventricular	O
pacing	O
@	O
60bpm.	O
ROS	O
is	O
notable	O
for	O
diarrhea	O
5	O
days	O
PTA	O
that	O
responded	O
to	O
immodium	O
which	O
then	O
recurred	O
3	O
days	O
PTA	O
but	O
resolved	O
yesterday.	O
At	O
it's	O
worse,	O
patient	O
had	O
___	O
loose	O
but	O
not	O
watery	O
stools.	O
Denies	O
any	O
dark	B-Upper_gastrointestinal_haemorrhage
stools	B-Upper_gastrointestinal_haemorrhage
or	O
BRBPR	B-Lower_gastrointestinal_haemorrhage
but	O
has	O
had	O
some	O
associated	O
lightheadedness.	O
Denies	O
chest	O
pain,	O
shortness	O
of	O
breath,	O
dysuria,	O
cough,	O
abdominal	O
pain.	O
REVIEW	O
OF	O
SYSTEMS:	O
On	O
review	O
of	O
systems,	O
she	O
denies	O
any	O
prior	O
history	O
of	O
stroke,	O
TIA,	O
deep	O
venous	O
thrombosis,	O
pulmonary	O
embolism,	O
bleeding	O
at	O
the	O
time	O
of	O
surgery,	O
myalgias,	O
joint	O
pains,	O
cough,	O
hemoptysis,	O
black	B-Upper_gastrointestinal_haemorrhage
stools	B-Upper_gastrointestinal_haemorrhage
or	O
red	B-Lower_gastrointestinal_haemorrhage
stools.	B-Lower_gastrointestinal_haemorrhage
She	O
denies	O
recent	O
fevers,	O
chills	O
or	O
rigors.	O
She	O
denies	O
exertional	O
buttock	O
or	O
calf	O
pain.	O
All	O
of	O
the	O
other	O
review	O
of	O
systems	O
were	O
negative.	O
Cardiac	O
review	O
of	O
systems	O
is	O
notable	O
for	O
absence	O
of	O
chest	O
pain,	O
dyspnea	O
on	O
exertion,	O
paroxysmal	O
nocturnal	O
dyspnea,	O
ankle	O
edema,	O
palpitations,	O
syncope	O
or	O
presyncope.	O
She	O
sleeps	O
in	O
a	O
recliner	O
at	O
baseline	O
but	O
has	O
not	O
had	O
not	O
had	O
to	O
change	O
the	O
steepness	O
of	O
her	O
recliner	O
over	O
the	O
past	O
few	O
weeks.	O
Past	O
Medical	O
History:	O
PAST	O
MEDICAL	O
HISTORY:	O
-	O
Dilated	O
cardiomyopathy	O
(LVEF	O
=	O
___	O
with	O
a	O
distal	O
akinesis,	O
felt	O
secondary	O
to	O
a	O
silent	O
myocardial	O
infarction	O
many	O
years	O
ago.	O
-	O
CAD	O
s/p	O
cath	O
___	O
demonstrating	O
a	O
twin	O
LAD	O
system	O
with	O
a	O
chronic	O
mid	O
to	O
lower	O
vessel	O
occlusion.	O
There	O
was	O
an	O
eccentric	O
60%	O
stenosis	O
in	O
the	O
major	O
OM	O
and	O
___	O
ostial	O
RCA	O
stenosis.	O
-	O
Hypertension.	O
-	O
Hyperlipidemia.	O
-	O
Paroxysmal	O
atrial	O
fibrillation	O
on	O
Coumadin	O
and	O
amiodarone.	O
-	O
ICD	O
implantation	O
for	O
primary	O
prevention	O
of	O
sudden	O
cardiac	O
death	O
-	O
Prior	O
history	O
of	O
hip	B-Hip_fracture
fracture	B-Hip_fracture
-	O
Arthritis	O
-	O
Obesity	O
-	O
Chronic	O
venous	O
stasis	O
-	O
Hypothyroidism	O
Social	O
History:	O
___	O
Family	O
History:	O
Mother	O
died	O
of	O
MI	O
in	O
her	O
___,	O
father	O
died	O
of	O
MI	O
in	O
his	O
___.	O
Physical	O
Exam:	O
ADMISSION	O
EXAM	O
==============	O
General:	O
Obese	O
woman,	O
lying	O
in	O
bed,	O
NAD	O
HEENT:	O
NC/AT,	O
EOMI,	O
oropharynx	O
clear	O
Neck:	O
RIJ	O
CVL	O
in	O
place,	O
supple,	O
unable	O
to	O
assess	O
JVP	O
due	O
to	O
body	O
habitus	O
CV:	O
Distant	O
heart	O
sounds,	O
RRR,	O
+S1/S2,	O
no	O
m/r/g	O
Lungs:	O
Trace	O
crackles	O
in	O
bilateral	O
bases,	O
otherwise	O
CTAB	O
Abdomen:	O
Obese,	O
soft,	O
NT/ND	O
GU:	O
No	O
Foley	O
Ext:	O
Extensive	O
hyperpigmentation	O
of	O
bilateral	O
lower	O
extremities	O
c/w	O
chronic	O
venous	O
stasis	O
changes.	O
Pain	O
with	O
palpation	O
but	O
no	O
erythema,	O
warmth.	O
No	O
pitting	O
edema	O
Neuro:	O
CN,	O
motor,	O
and	O
sensation	O
grossly	O
intact.	O
Moves	O
extremities	O
sponatenously	O
PULSES:	O
DP	O
pulses	O
dopplerable	O
bilaterally	O
DISCHARGE	O
EXAM	O
==============	O
VS:	O
97.7	O
106-115/49-69,	O
___,	O
22,	O
97%RA	O
I/O:	O
24HR	O
___	O
8HR:	O
___	O
Wt:	O
110.4	O
(111.6)	O
GENERAL:	O
Obese	O
woman,	O
lying	O
in	O
bed,	O
NAD	O
HEENT:	O
NC/AT,	O
EOMI,	O
oropharynx	O
clear	O
Neck:	O
Supple,	O
JVD	O
about	O
___	O
up	O
sitting	O
in	O
chair	O
CV:	O
Distant	O
heart	O
sounds,	O
RRR,	O
___	O
systolic	O
murmur	O
at	O
RUSB	O
Lungs:	O
crackles	O
in	O
bilateral	O
bases,	O
otherwise	O
CTAB	O
Abdomen:	O
Obese,	O
soft,	O
NT/ND,	O
bowel	O
sounds	O
presetn	O
GU:	O
No	O
Foley	O
Ext:	O
Extensive	O
hyperpigmentation	O
of	O
bilateral	O
lower	O
extremities	O
c/w	O
chronic	O
venous	O
stasis	O
changes.	O
Pain	O
with	O
palpation	O
but	O
no	O
erythema,	O
warmth.	O
2+	O
pitting	O
edema	O
in	O
bilateral	O
feet/ankles	O
Neuro:	O
CN,	O
motor,	O
and	O
sensation	O
grossly	O
intact.	O
Moves	O
extremities	O
sponatenously	O
PULSES:	O
DP	O
pulses	O
dopplerable	O
bilaterally	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
==============	O
___	O
11:50AM	O
BLOOD	O
WBC-6.7	O
RBC-3.39*	O
Hgb-11.4*	O
Hct-36.1	O
MCV-107*#	O
MCH-33.5*	O
MCHC-31.5	O
RDW-14.2	O
Plt	O
___	O
___:00PM	O
BLOOD	O
Neuts-71.1*	O
___	O
Monos-7.7	O
Eos-2.4	O
Baso-0.8	O
___	O
11:50AM	O
BLOOD	O
UreaN-105*	O
Creat-3.9*#	O
Na-136	O
K-5.6*	O
Cl-104	O
HCO3-20*	O
AnGap-18	O
___	O
11:50AM	O
BLOOD	O
Glucose-89	O
___	O
02:00PM	O
BLOOD	O
ALT-13	O
AST-16	O
AlkPhos-84	O
TotBili-0.3	O
___	O
02:00PM	O
BLOOD	O
Albumin-4.4	O
Calcium-8.2*	O
Phos-5.4*#	O
Mg-2.7*	O
___	O
05:05PM	O
BLOOD	O
Type-CENTRAL	O
VE	O
pO2-64*	O
pCO2-41	O
pH-7.27*	O
calTCO2-20*	O
Base	O
XS--7	O
Comment-GREEN	O
TOP	O
___	O
05:05PM	O
BLOOD	O
Lactate-0.9	O
PERTINENT	O
LABS	O
==============	O
___	O
01:17AM	O
BLOOD	O
WBC-9.1	O
RBC-3.26*	O
Hgb-10.7*	O
Hct-34.4*	O
MCV-106*	O
MCH-32.7*	O
MCHC-31.0	O
RDW-14.2	O
Plt	O
___	O
___	O
11:16PM	O
BLOOD	O
Glucose-152*	O
UreaN-94*	O
Creat-3.5*	O
Na-135	O
K-9.4*	O
Cl-106	O
HCO3-17*	O
AnGap-21*	O
___	O
01:17AM	O
BLOOD	O
Calcium-7.9*	O
Phos-4.4	O
Mg-2.5	O
___	O
04:55AM	O
BLOOD	O
WBC-5.0	O
RBC-2.81*	O
Hgb-9.3*	O
Hct-29.8*	O
MCV-106*	O
MCH-33.2*	O
MCHC-31.3	O
RDW-14.1	O
Plt	O
___	O
___	O
04:55AM	O
BLOOD	O
Glucose-82	O
UreaN-67*	O
Creat-2.1*	O
Na-137	O
K-5.7*	O
Cl-113*	O
HCO3-20*	O
AnGap-10	O
___	O
04:55AM	O
BLOOD	O
Calcium-7.6*	O
Phos-4.0	O
Mg-2.3	O
___	O
08:01AM	O
BLOOD	O
WBC-4.6	O
RBC-2.94*	O
Hgb-9.8*	O
Hct-31.3*	O
MCV-106*	O
MCH-33.2*	O
MCHC-31.2	O
RDW-14.2	O
Plt	O
___	O
___	O
08:01AM	O
BLOOD	O
Glucose-101*	O
UreaN-51*	O
Creat-1.7*	O
Na-139	O
K-5.9*	O
Cl-110*	O
HCO3-21*	O
AnGap-14	O
___	O
06:15AM	O
BLOOD	O
Glucose-90	O
UreaN-48*	O
Creat-1.6*	O
Na-140	O
K-5.9*	O
Cl-110*	O
HCO3-22	O
AnGap-14	O
ANTICOAGULATION	O
===============	O
___	O
02:00PM	O
BLOOD	O
___	O
PTT-44.2*	O
___	O
___	O
01:17AM	O
BLOOD	O
___	O
___	O
06:27AM	O
BLOOD	O
___	O
PTT-43.9*	O
___	O
___	O
04:55AM	O
BLOOD	O
___	O
PTT-44.4*	O
___	O
___	O
08:01AM	O
BLOOD	O
___	O
___	O
08:50AM	O
BLOOD	O
___	O
PTT-40.0*	O
___	O
CARDIAC	O
BIOMARKERS	O
==================	O
___	O
02:00PM	O
BLOOD	O
proBNP-3050*	O
___	O
02:00PM	O
BLOOD	O
cTropnT-0.05*	O
___	O
11:16PM	O
BLOOD	O
CK-MB-3	O
cTropnT-0.05*	O
DISCHARGE	O
LABS	O
==============	O
___	O
07:10AM	O
BLOOD	O
Glucose-87	O
UreaN-50*	O
Creat-1.8*	O
Na-141	O
K-4.5	O
Cl-106	O
HCO3-27	O
AnGap-13	O
MICROBIOLOGY	O
============	O
___	O
MRSA	O
SCREEN	O
MRSA	O
SCREEN-NO	O
MRSA	O
ISOLATED	O
___	O
URINE	O
CULTURE-NO	O
GROWTH	O
___	O
Blood	O
Culture,	O
Routine-PENDING	O
___	O
Blood	O
Culture,	O
Routine-PENDING	O
IMAGING	O
=======	O
EKG	O
___	O
Regular	O
wide	O
complex	O
rhythm	O
without	O
convincing	O
organzied	O
P	O
wave	O
activity.	O
Right	O
axis	O
deviation	O
with	O
left	O
bundle-branch	O
block	O
morphology	O
and	O
the	O
morphological	O
pattern	O
of	O
the	O
QRS	O
complex	O
suggests	O
accelerated	O
idioventricular	O
rhythm	O
with	O
secondary	O
repolarization	O
abnormalities.	O
Prolonged	O
Q-T	O
interval.	O
Compared	O
to	O
the	O
previous	O
tracing	O
of	O
___	O
ventricular	O
arrhythmia	O
has	O
replaced	O
atrial	O
pacing	O
with	O
P-R	O
interval	O
prolongation.	O
Current	O
QRS	O
configuration	O
is	O
unlike	O
any	O
of	O
the	O
prior	O
QRS	O
morphologies	O
seen	O
with	O
ventricular	O
pacing	O
or	O
native	O
left	O
bundle-branch	O
block.	O
ST	O
segment	O
elevation	O
in	O
leads	O
I,	O
aVL	O
and	O
V2	O
most	O
likely	O
secondary	O
to	O
the	O
conduction	O
abnormality.	O
An	O
ongoing	O
ischemic	O
process	O
with	O
ventricular	O
arrhythmia	O
cannot	O
be	O
excluded.	O
Clinical	O
correlation	O
is	O
suggested.	O
Wide	O
complex	O
with	O
a	O
downward	O
frontal	O
plane	O
axis	O
argues	O
against	O
ventricular	O
pacing	O
as	O
an	O
explanation.	O
Intervals	O
Axes	O
Rate	O
PR	O
QRS	O
QT/QTc	O
P	O
QRS	O
T	O
82	O
92	O
___	O
0	O
0	O
0	O
ECHO	O
___	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
severely	O
depressed	O
(LVEF	O
=	O
___	O
%).	O
The	O
right	O
ventricular	O
free	O
wall	O
thickness	O
is	O
normal.	O
Right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
with	O
borderline	O
normal	O
free	O
wall	O
function.	O
There	O
is	O
an	O
anterior	O
space	O
which	O
most	O
likely	O
represents	O
a	O
prominent	O
fat	O
pad.	O
Compared	O
with	O
the	O
prior	O
study	O
(images	O
reviewed)	O
of	O
___,	O
no	O
major	O
change	O
is	O
evident,	O
but	O
the	O
technically	O
suboptimal	O
nature	O
of	O
both	O
studies	O
precludes	O
definitive	O
comparison.	O
CXR	O
___	O
IMPRESSION:	O
Cardiomegaly	O
with	O
no	O
acute	O
intrathoracic	O
process.	O
Stable	O
calcified	O
rounded	O
density	O
in	O
the	O
left	O
lung	O
base	O
is	O
unchanged	O
and	O
relates	O
to	O
a	O
calcified	O
left	O
ventricular	O
aneurysm.	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
a	O
___	O
with	O
sCHF	O
(EF	O
25%	O
in	O
___	O
s/p	O
ICD	O
placement,	O
CAD	O
with	O
twin	O
LAD	O
system	O
on	O
___	O
cath,	O
and	O
AFib	O
on	O
coumadin	O
who	O
presented	O
for	O
abnormal	O
EKG	O
findings	O
found	O
to	O
be	O
hypotensive.	O
#	O
Hypotension:	O
Initial	O
differential	O
diagnosis	O
included	O
hypovolemia,	O
infection/sepsis,	O
cardiogenic	O
shock,	O
and	O
arrhythmia	O
with	O
decreased	O
diastolic	O
filling	O
time	O
and	O
decreased	O
forward	O
flow.	O
Most	O
likely	O
etiology	O
is	O
hypovolemia	O
given	O
recent	O
diarrhea	O
and	O
ongoing	O
diuretic	O
use.	O
Infectious	O
work-up	O
negative	O
and	O
patient	O
without	O
fevers	O
or	O
other	O
signs/sx	O
of	O
infection.	O
No	O
signs	O
of	O
decompensated	O
heart	O
failure	O
on	O
radiology	O
or	O
exam.	O
She	O
initially	O
required	O
levophed,	O
which	O
was	O
weaned	O
off	O
with	O
the	O
help	O
of	O
small	O
volume	O
fluid	O
boluses.	O
Orthostatics	O
were	O
negative	O
after	O
levophed	O
weaned.	O
#	O
CHF:	O
EF	O
of	O
25%	O
in	O
___	O
s/p	O
AICD.	O
Home	O
regimen	O
is	O
spironolactone	O
25mg	O
daily,	O
torsemide	O
10mg	O
daily,	O
metoprolol	O
25XL	O
at	O
home.	O
proBNP	O
was	O
elevated	O
on	O
admission,	O
though	O
she	O
appeared	O
euvolemic	O
on	O
exam.	O
Home	O
spironolactone,	O
torsemide,	O
and	O
metoprolol	O
were	O
initially	O
held	O
in	O
the	O
setting	O
of	O
hypotension.	O
Torsemide	O
and	O
metoprolol	O
were	O
restarted	O
when	O
her	O
blood	O
pressures	O
were	O
stable	O
and	O
within	O
normal	O
limits.	O
Spironolactone	O
was	O
held	O
given	O
her	O
hyperkalemia.	O
#	O
Acute	O
on	O
Chronic	O
kidney	O
disease:	O
Patient	O
presented	O
with	O
a	O
Creatinine	O
of	O
3.9,	O
baseline	O
per	O
OMR	O
0.8-1.3.	O
Likely	O
pre-renal	O
in	O
etiology	O
given	O
BUN/Cr	O
and	O
recent	O
history	O
of	O
diarrhea	O
with	O
continued	O
diuretic	O
use.	O
FeUrea	O
(recent	O
diuretic	O
use)	O
<35%	O
c/w	O
pre-renal	O
etiology.	O
Improved	O
to	O
___	O
s/p	O
fluid	O
boluses,	O
and	O
on	O
discharge	O
was	O
1.8.	O
#	O
Hyperkalemia:	O
Potassium	O
on	O
admission	O
was	O
5.6	O
and	O
increased	O
to	O
peak	O
of	O
5.9	O
without	O
any	O
EKG	O
changes.	O
Most	O
likely	O
___	O
___	O
in	O
the	O
setting	O
of	O
spironolactone	O
and	O
ace-inhibitor.	O
Spironolactone	O
and	O
lisinopril	O
were	O
initially	O
held	O
and	O
hyperkalemia	O
was	O
treated	O
with	O
kayexylate.	O
K	O
on	O
discharge	O
was	O
4.5	O
and	O
spironolactone	O
was	O
held.	O
#	O
Atrial	O
Fibrillation:	O
Patient	O
with	O
CHADS2	O
score	O
of	O
3,	O
currently	O
on	O
metoprolol	O
and	O
warfarin	O
as	O
an	O
outpatient.	O
INR	O
supratherapeutic	O
to	O
3.7	O
on	O
admission.	O
Warfarin	O
restarted	O
at	O
1	O
mg	O
when	O
INR	O
3.1.	O
Metoprolol	O
restarted	O
when	O
blood	O
pressures	O
stabilized	O
as	O
above.	O
#	O
Diarrhea:	O
Patient	O
endorsed	O
diarrhea	O
5	O
days	O
prior	O
to	O
admission	O
that	O
responded	O
to	O
immodium	O
which	O
then	O
recurred	O
3	O
days	O
PTA	O
but	O
resolved	O
on	O
the	O
day	O
prior	O
to	O
admission.	O
Likely	O
a	O
large	O
contributing	O
factor	O
to	O
the	O
patient's	O
hypotension.	O
At	O
its	O
worst,	O
the	O
patient	O
had	O
___	O
loose	O
but	O
not	O
watery	O
stools.	O
She	O
denied	O
any	O
dark	B-Upper_gastrointestinal_haemorrhage
stools	B-Upper_gastrointestinal_haemorrhage
or	O
BRBPR	B-Lower_gastrointestinal_haemorrhage
but	O
has	O
had	O
some	O
associated	O
lightheadedness.	O
She	O
had	O
no	O
further	O
episodes	O
of	O
diarrhea	O
during	O
her	O
hospitalization.	O
#	O
Hyperlipidemia:	O
Continued	O
with	O
home	O
Atorvastastin	O
10	O
mg	O
#	O
Hypothyroidism:	O
Continued	O
with	O
home	O
Levothyroxine	O
75	O
mcg	O
#	O
GERD:	O
Continued	O
with	O
home	O
Ranitidine	O
150	O
mg	O
BID	O
Transitional	O
Issue:	O
-	O
Please	O
trend	O
creatinine	O
to	O
monitor	O
kidney	O
function,	O
likely	O
some	O
component	O
of	O
baseline	O
CKD,	O
baseline	O
creatinine	O
0.8-1.3	O
-	O
Spironolactone	O
held	O
during	O
hospitalization	O
due	O
to	O
hyperkalemia.	O
-	O
Toursemide	O
restarted	O
at	O
10mg	O
daily,	O
please	O
monitor	O
weights	O
daily.	O
Dry	O
weight	O
likely	O
230-235	O
pounds	O
-	O
Cyst	O
removal	O
postponed,	O
will	O
need	O
to	O
reschedule	O
per	O
Dr.	O
___	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Acetaminophen	O
1000	O
mg	O
PO	O
BID	O
2.	O
Amiodarone	O
200	O
mg	O
PO	O
DAILY	O
3.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
4.	O
Atorvastatin	O
10	O
mg	O
PO	O
DAILY	O
5.	O
Levothyroxine	O
Sodium	O
75	O
mcg	O
PO	O
DAILY	O
6.	O
Lisinopril	O
5	O
mg	O
PO	O
DAILY	O
7.	O
Ranitidine	O
150	O
mg	O
PO	O
BID	O
8.	O
Warfarin	O
1.5	O
mg	O
PO	O
DAYS	O
(MO,WE)	O
9.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
10.	O
Vitamin	O
D	O
50,000	O
UNIT	O
PO	O
QMONTH	O
11.	O
Spironolactone	O
12.5	O
mg	O
PO	O
DAILY	O
12.	O
Torsemide	O
10	O
mg	O
PO	O
DAILY	O
13.	O
Warfarin	O
1	O
mg	O
PO	O
DAYS	O
(___)	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
325-650	O
mg	O
PO	O
Q6H:PRN	O
pain	O
2.	O
Amiodarone	O
200	O
mg	O
PO	O
DAILY	O
3.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
4.	O
Atorvastatin	O
10	O
mg	O
PO	O
DAILY	O
5.	O
Ranitidine	O
150	O
mg	O
PO	O
BID	O
6.	O
Levothyroxine	O
Sodium	O
75	O
mcg	O
PO	O
DAILY	O
7.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
8.	O
Vitamin	O
D	O
50,000	O
UNIT	O
PO	O
QMONTH	O
9.	O
Torsemide	O
10	O
mg	O
PO	O
DAILY	O
10.	O
Warfarin	O
1.5	O
mg	O
PO	O
DAYS	O
(MO,WE)	O
11.	O
Warfarin	O
1	O
mg	O
PO	O
DAYS	O
(___)	O
12.	O
Lisinopril	O
5	O
mg	O
PO	O
DAILY	O
Hols	O
SBP	O
<	O
90	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary	O
Diagnosis:	O
Hypotension	O
Secondary	O
Diagnoses:	O
___	O
CHF	O
Atrial	O
fibrillation	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
(rolling	I-Mobile_with_aid
walker).	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
CCU	O
for	O
close	O
monitoring	O
because	O
your	O
blood	O
pressure	O
was	O
found	O
to	O
be	O
very	O
low.	O
This	O
was	O
likely	O
due	O
to	O
several	O
episodes	O
of	O
diarrhea	O
you	O
had	O
in	O
the	O
days	O
leading	O
up	O
to	O
your	O
hospitalization.	O
Your	O
blood	O
pressure	O
increased	O
to	O
a	O
normal	O
range	O
with	O
fluids.	O
After	O
you	O
had	O
the	O
fluids,	O
you	O
were	O
found	O
to	O
have	O
swelling	O
in	O
your	O
feet	O
and	O
ankles.	O
Additional	O
torsemide	O
was	O
given	O
to	O
remove	O
the	O
extra	O
fluid.	O
You	O
will	O
need	O
to	O
weigh	O
yourself	O
every	O
day	O
without	O
fail	O
in	O
the	O
morning	O
before	O
breakfast.	O
Call	O
Dr.	O
___	O
your	O
weight	O
increases	O
more	O
than	O
3	O
pounds	O
in	O
1	O
day	O
or	O
5	O
pounds	O
in	O
3	O
days.	O
Your	O
weight	O
at	O
discharge	O
is	O
142	O
pounds	O
and	O
your	O
goal	O
weight	O
is	O
135	O
pounds.	O
Followup	O
Instructions:	O
___	O

